Vermox 500 mg, Tabletten - 100 Tablette(n) Swissmedic Key 38853023 Registration Holder JNTL Consumer Health II (Switzerland) GmbH Name Vermox 500 mg, Tabletten Date of registration 18.12.1974 Introduction of Sequence 20.09.1989 ATC-Classification Mebendazole (P02CA01) Revision date 07.01.2005 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.05.10. Show package size 100 Tablette(n) Index Therapeuticus (Swissmedic) 08.05.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price 152.20 Deductible k.A. Consumer price 181.95 Feedback FB Daily cost GTIN 7680388530233 Medication Code Synthetika Pharmacode 1373944 Disponibility
Composition mebendazolum 500 mg, lactosum monohydricum 34 mg, methylcellulosum, carboxymethylamylum natricum A corresp. natrium 2.23 mg, cellulosum microcristallinum, maydis amylum, magnesii stearas, silica colloidalis anhydrica, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Mebendazole 500 mg
BAG: Active Agent Dose Mebendazole 500 mg
Inactive agents Dose Carboxymethylamylum Natricum A Cellulosum Microcristallinum Lactose Monohydrate 34 mg Magnesii Stearas Maydis Amylum Methylcellulosum Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 05.01.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
